In this renewal application for the UCSD HIV Neurobehavioral Research Center (HNRC) we propose to provide scientific expertise and infrastructure to support studies that better elucidate current theories, and develop new insights, into the mechanisms behind the development and persistence of HIV-associated neurocognitive disorders (HAND). In particular, the HNRC is positioning itself to facilitate studies addressing important new research themes, including persistence and eradication of HIV in the CNS (cure agenda) and the role of alterations in the gut microbiota as a contributor to HAND. To accomplish this we have recruited world-class investigators in these fields to the HNRC. Since studies of microbiome effects and eradication may be most informative in the earliest stages of infection and treatment, we will establish a major new partnership with UCSD's primary infection screening program, which will enrich the HNRC cohort with primary infection cases. A longitudinal cohort of HIV+ and HIV- participants, to ultimately include 100 primary infection cases, will be comprehensively examined to facilitate/enable supported studies. This renewal builds on the track record of the HNRC as a national and international leader and resource facilitating research on neuropathogenesis, treatment, and prevention of HAND. Ongoing, continuity areas of emphasis are to support studies examining a) mechanisms of aging and HIV interaction, whereby aging and HIV may interact in determining an increased occurrence, as well as possible differences in features, prognosis, and treatment challenges for neuroAIDS in older individuals, addressing the OAR priority to investigate premature aging associated with long-term HIV disease and ART, and b) clinical relevance: new treatments/biomarkers/new methods (e.g., Do new ARV and non-ARV treatments alter the development of HAND? What additional biomarkers can be identified/developed to better detect and predict HAND? How can these and other tools be translated into methods that are useful in the clinic?). To accomplish these goals, we are proposing a streamlined and better integrated organization of the HNRC into 3 scientific Cores (NeuroAssessment, NeuroGerm, and NeuroBiology) that will provide intellectual leadership and technical support, with an Administrative Core to support and coordinate their activities; and a Developmental Core, which will support innovative preliminary studies and coordinate training and mentorship with the scientific cores and HNRC-associated faculty, targeting the future generation of neuro- HIV scientists. In addition to our numerous U.S. collaborations in neuroAIDS research, the international component of the Developmental Core will provide consultation to international scholars, help translate techniques developed at the HNRC to diverse settings around the world, and support joint research efforts between U.S. and foreign investigators. With these structures and processes the HNRC will continue to foster its national and international leadership role in vital neuro-HIV research, training, and treatment.

Public Health Relevance

Despite treatment advances, people with HIV infection often still develop neurologic problems. The HIV Neurobehavioral Research Center (HNRC) will provide scientific leadership and technical support for innovative studies that address the neuropathogenesis, continued persistence and treatment of HIV-associated neurocognitive disorders (HAND). Areas of special emphasis will include HIV eradication and 'cure' within the CNS and alterations in the gut microbiota as a contributor to neurocognitive impairment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH062512-18
Application #
9438566
Study Section
Special Emphasis Panel (ZMH1)
Program Officer
Joseph, Jeymohan
Project Start
2001-04-24
Project End
2021-02-28
Budget Start
2018-03-01
Budget End
2019-02-28
Support Year
18
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Psychiatry
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
de Almeida, Sérgio Monteiro; Ribeiro, Clea E; Rotta, Indianara et al. (2018) Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C. J Neurovirol 24:28-40
Dubé, Karine; Gianella, Sara; Concha-Garcia, Susan et al. (2018) Ethical considerations for HIV cure-related research at the end of life. BMC Med Ethics 19:83
Paolillo, Emily W; McKenna, Benjamin S; Nowinski, Cindy J et al. (2018) NIH Toolbox® Emotion Batteries for Children: Factor-Based Composites and Norms. Assessment :1073191118766396
Jumare, Jibreel; El-Kamary, Samer S; Magder, Laurence et al. (2018) Body Mass Index and Cognitive Function among HIV-1 Infected Individuals in China, India and Nigeria. J Acquir Immune Defic Syndr :
Alakkas, Aljoharah; Ellis, Ronald J; Watson, Caitlin Wei-Ming et al. (2018) White matter damage, neuroinflammation, and neuronal integrity in HAND. J Neurovirol :
de Almeida, Sérgio Monteiro; de Pereira, Ana Paula; Pedroso, Maria Lucia Alves et al. (2018) Neurocognitive impairment with hepatitis C and HIV co-infection in Southern Brazil. J Neurovirol 24:339-349
Rubtsova, Anna A; Marquine, María J; Depp, Colin et al. (2018) Psychosocial Correlates of Frailty Among HIV-Infected and HIV-Uninfected Adults. Behav Med :1-11
Basova, Liana; Najera, Julia A; Bortell, Nikki et al. (2018) Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: Implications to HIV infection. PLoS One 13:e0199861
Anderson, Albert M; Tyor, William R; Mulligan, Mark J et al. (2018) Measurement of Human Immunodeficiency Virus p24 Antigen in Human Cerebrospinal Fluid With Digital Enzyme-Linked Immunosorbent Assay and Association With Decreased Neuropsychological Performance. Clin Infect Dis 67:137-140
Raj, Anita; Yore, Jennifer; Urada, Lianne et al. (2018) Multi-Site Evaluation of Community-Based Efforts to Improve Engagement in HIV Care Among Populations Disproportionately Affected by HIV in the United States. AIDS Patient Care STDS 32:438-449

Showing the most recent 10 out of 743 publications